Evidence map›Paper›PMID 26198208›Full record

ReviewOrphanet journal of rare diseases2015

Idiopathic (primary) achalasia: a review.

Dhyanesh A Patel, Hannah P Kim, Jerry S Zifodya, Michael F Vaezi

Open access · goldAbstract readReview
In one paragraph

Review in Orphanet journal of rare diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Achalasia Cardia: A Case Series.JNMA; journal of the Nepal Medical Association · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Soluble Guanylate Cyclase Stimulators and Activators.Handbook of experimental pharmacology · 2021
    Article
  10. Comparison of Oral and Esophageal Microbiota in Patients with Achalasia Before and After Peroral Endoscopic Myotomy.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2021
    Observational
  11. Article
  12. Article
  13. Achalasia cardia: A diagnosis often delayed!Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2019
    Article
  14. Article
  15. An Overview of Achalasia and Its Subtypes.Gastroenterology & hepatology · 2017
    Article
  16. Anaesthetic Management of a Case of Down's Syndrome with Achalasia Cardia.Journal of clinical and diagnostic research : JCDR · 2016
    Article
  17. Review
  18. Prosthetic rehabilitation in patient with achalasia cardia - A rare case report.Journal of International Society of Preventive & Community Dentistry
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Dhyanesh A PatelDepartment of Internal Medicine, Nashville, TN, USA.
Hannah P KimDepartment of Internal Medicine, Nashville, TN, USA.
Jerry S ZifodyaDepartment of Internal Medicine, Nashville, TN, USA.
Michael F VaeziDivision of Gastroenterology, Hepatology and Nutrition, Vanderbilt University Medical Center, Nashville, TN, USA. Michael.vaezi@vanderbilt.edu.
University School of Nashville · USVanderbilt University Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Idiopathic achalasia is a primary esophageal motor disorder characterized by loss of esophageal peristalsis and insufficient lower esophageal sphincter relaxation in response to deglutition. Patients with achalasia commonly complain of dysphagia to solids and liquids, bland regurgitation often unresponsive to an adequate trial of proton pump inhibitor, and chest pain. Weight loss is present in many, but not all patients. Although the precise etiology is unknown, it is often thought to be either autoimmune, viral immune, or neurodegenerative. The diagnosis is based on history of the disease, barium esophagogram, and esophageal motility testing. Endoscopic assessment of the gastroesophageal junction and gastric cardia is necessary to rule out malignancy. Newer diagnostic modalities such as high resolution manometry help in predicting treatment response in achalasia based on esophageal pressure topography patterns identifying three phenotypes of achalasia (I-III) and outcome studies suggest better treatment response with types I and II compared to type III. Although achalasia cannot be permanently cured, excellent outcomes are achieved in over 90 % of patients. Current medical and surgical therapeutic options (pneumatic dilation, endoscopic and surgical myotomy, and pharmacologic agents) aim at reducing the LES pressure and facilitating esophageal emptying by gravity and hydrostatic pressure of retained food and liquids. Either graded pneumatic dilatation or laparoscopic surgical myotomy with a partial fundoplication are recommended as initial therapy guided by patient age, gender, preference, and local institutional expertise. The prognosis in achalasia patients is excellent. Most patients who are appropriately treated have a normal life expectancy but the disease does recur and the patient may need intermittent treatment.

Indexed as

BariumEsophageal AchalasiaEsophagoscopyEsophagusGastroesophageal RefluxHumansRadiographyBarium

Identifiers

PMID26198208
PMCPMC4509143
OpenAlexW1492217685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.